Osteoarthritis Therapeutics Market Size

  • Report ID: 195
  • Published Date: Sep 04, 2024
  • Report Format: PDF, PPT

Osteoarthritis Therapeutics Market Size

Osteoarthritis Therapeutics Market size was valued at USD 8.73 billion in 2023 and is expected to exceed USD 20.28 billion by 2036, registering over 6.7% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of osteoarthritis therapeutics is assessed at USD 9.2 billion.

The growth of the market can be attributed to the increased number of patients with osteoarthritis. Osteoarthritis is a type of arthritis that occurs when flexible tissue at the ends of bone wears down. The main factor for the rise of osteoarthritis is the increasing number of geriatric population. According to the report published by United Nations, there were 703 million people aged 65 years or over in the world in 2019. Hence on the back of the increasing geriatric population, the market is estimated to witness remarkable growth during the forecast period. Moreover, the World Obesity Atlas 2022 report published by the World Obesity Federation predicts that 1 billion people globally, including 1 in 7 men and 1 in 5 women will be living with obesity by 2030. Obesity is also a primary factor that contributes to the development of osteoarthritis. The excess weight adds pressure and stress on joint, and fat cells promote inflammation. Additionally, osteoarthritis is also caused by joint injuries such as bone fracture, cartilage, or ligament tear. Posttraumatic osteoarthritis is the occurrence of arthritis after a trauma or an accident. The condition is becoming common and it is estimated that approximately 10% of osteoarthritis cases of the knee, ankle, and hip are the result of trauma or accident. Owing to surging accidental cases the market is expected to grow during the forecast period.


Osteoarthritis Treatment Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 195
  • Published Date: Sep 04, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of osteoarthritis therapeutics is assessed at USD 9.2 billion.

Osteoarthritis Therapeutics Market size was valued at USD 8.73 billion in 2023 and is expected to exceed USD 20.28 billion by 2036, registering over 6.7% CAGR during the forecast period i.e., between 2024-2036. The growing cases of osteoarthritis and obesity will impel the market growth.

North America is set to account for largest revenue share by 2036, on the back of presence of ultra-modern healthcare infrastructure in the region.

The major players in the market are Bayer AG, Horizon Therapeutics plc, and Johnson & Johnson Services, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample